HomeCompareKRYAF vs JNJ

KRYAF vs JNJ: Dividend Comparison 2026

KRYAF yields 1.89% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KRYAF wins by $253.2K in total portfolio value
10 years
KRYAF
KRYAF
● Live price
1.89%
Share price
$77.19
Annual div
$1.46
5Y div CAGR
61.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$273.3K
Annual income
$147,661.53
Full KRYAF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — KRYAF vs JNJ

📍 KRYAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKRYAFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KRYAF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KRYAF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KRYAF
Annual income on $10K today (after 15% tax)
$160.84/yr
After 10yr DRIP, annual income (after tax)
$125,512.30/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, KRYAF beats the other by $124,808.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KRYAF + JNJ for your $10,000?

KRYAF: 50%JNJ: 50%
100% JNJ50/50100% KRYAF
Portfolio after 10yr
$146.6K
Annual income
$74,244.66/yr
Blended yield
50.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KRYAF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
3.8
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KRYAF buys
0
JNJ buys
0
No recent congressional trades found for KRYAF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKRYAFJNJ
Forward yield1.89%3.36%
Annual dividend / share$1.46$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR61.7%5.8%
Portfolio after 10y$273.3K$20.0K
Annual income after 10y$147,661.53$827.78
Total dividends collected$240.3K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: KRYAF vs JNJ ($10,000, DRIP)

YearKRYAF PortfolioKRYAF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,006$305.98$10,676$355.77+$330.00KRYAF
2$12,285$508.92$11,407$389.39+$878.00KRYAF
3$14,004$858.49$12,198$426.53+$1.8KKRYAF
4$16,463$1,478.84$13,056$467.62+$3.4KKRYAF
5$20,243$2,627.30$13,987$513.12+$6.3KKRYAF
6$26,542$4,881.98$14,998$563.56+$11.5KKRYAF
7$38,073$9,673.47$16,098$619.52+$22.0KKRYAF
8$61,708$20,969.99$17,295$681.69+$44.4KKRYAF
9$117,391$51,362.93$18,599$750.82+$98.8KKRYAF
10$273,269$147,661.53$20,022$827.78+$253.2KKRYAF

KRYAF vs JNJ: Complete Analysis 2026

KRYAFStock

Kerry Group plc, together with its subsidiaries, develops, manufactures, and delivers taste and nutrition solutions for the food, beverage, and pharmaceutical industries in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates in two segments, Taste & Nutrition and Consumer Foods. The Taste & Nutrition segment provides taste, nutrition, and functional ingredients technologies and solutions for the food, beverage, and pharmaceutical markets. The Consumer Foods segment manufactures and supplies customer branded chilled food products primarily to the Irish and the United Kingdom markets. Kerry Group plc was founded in 1972 and is headquartered in Tralee, Ireland.

Full KRYAF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this KRYAF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KRYAF vs SCHDKRYAF vs JEPIKRYAF vs OKRYAF vs KOKRYAF vs MAINKRYAF vs ABBVKRYAF vs MRKKRYAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.